Organon & Co.
OGN
$13.31
-$0.02-0.15%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.50% | -5.34% | 1.26% | -0.81% | -6.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.50% | -5.34% | 1.26% | -0.81% | -6.72% |
| Cost of Revenue | 1.06% | 6.47% | 11.23% | 4.94% | -0.30% |
| Gross Profit | -7.06% | -14.51% | -5.85% | -4.90% | -11.18% |
| SG&A Expenses | 0.95% | -6.10% | -1.66% | 3.66% | -2.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.68% | -1.71% | 3.36% | 2.29% | -2.40% |
| Operating Income | -18.26% | -20.52% | -5.13% | -10.62% | -19.32% |
| Income Before Tax | 110.89% | -214.73% | 17.39% | -2.55% | -57.20% |
| Income Tax Expenses | 378.57% | 185.00% | 154.61% | 110.00% | -60.00% |
| Earnings from Continuing Operations | 67.82% | -288.07% | -55.43% | -25.64% | -56.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.82% | -288.07% | -55.43% | -25.64% | -56.72% |
| EBIT | -18.26% | -20.52% | -5.13% | -10.62% | -19.32% |
| EBITDA | -14.11% | -11.46% | 0.65% | -3.98% | -12.73% |
| EPS Basic | 66.18% | -286.26% | -55.86% | -26.40% | -57.08% |
| Normalized Basic EPS | -16.65% | -31.54% | -2.11% | -19.23% | -26.89% |
| EPS Diluted | 66.67% | -291.42% | -55.80% | -25.63% | -57.69% |
| Normalized Diluted EPS | -16.44% | -30.95% | -1.51% | -18.88% | -27.02% |
| Average Basic Shares Outstanding | 0.97% | 0.96% | 0.96% | 1.03% | 0.85% |
| Average Diluted Shares Outstanding | 0.73% | 0.11% | 0.34% | 0.60% | 1.02% |
| Dividend Per Share | -92.86% | -92.86% | -92.86% | -92.86% | 0.00% |
| Payout Ratio | -0.96% | -1.03% | -0.91% | -0.83% | 1.34% |